These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38684519)

  • 21. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
    Guo X; Luo S; Amidani D; Rivetti C; Pieraccini G; Pioselli B; Catinella S; Murgia X; Salomone F; Xu Y; Dong Y; Sun B
    PLoS One; 2020; 15(3):e0230229. PubMed ID: 32168331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition.
    Echaide M; Autilio C; López-Rodríguez E; Cruz A; Pérez-Gil J
    Sci Rep; 2020 Jan; 10(1):1385. PubMed ID: 31992800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic surfactant with a combined SP-B and SP-C analogue is efficient in rabbit models of adult and neonatal respiratory distress syndrome.
    Mikolka P; Kronqvist N; Haegerstrand-Björkman M; Jaudzems K; Kosutova P; Kolomaznik M; Saluri M; Landreh M; Calkovska A; Curstedt T; Johansson J
    Transl Res; 2023 Dec; 262():60-74. PubMed ID: 37499744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury.
    Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D
    J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effects of the new generation synthetic surfactant CHF5633 on Ureaplasma-induced cytokine responses in human monocytes.
    Glaser K; Fehrholz M; Henrich B; Claus H; Papsdorf M; Speer CP
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):181-189. PubMed ID: 27828734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury.
    Cattel F; Giordano S; Bertiond C; Lupia T; Corcione S; Scaldaferri M; Angelone L; De Rosa FG
    Respir Physiol Neurobiol; 2021 Jun; 288():103645. PubMed ID: 33657448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant.
    van Zyl JM; Smith J
    Drug Des Devel Ther; 2013; 7():905-16. PubMed ID: 24039400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
    Häfner D; Germann PG
    J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant with SP-B and SP-C analogues improves lung function in surfactant-deficient rats.
    Walther FJ; Hernández-Juviel JM; Mercado PE; Gordon LM; Waring AJ
    Biol Neonate; 2002; 82(3):181-7. PubMed ID: 12373069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant replacement and open lung concept--comparison of two treatment strategies in an experimental model of neonatal ARDS.
    Hilgendorff A; Aslan E; Schaible T; Gortner L; Baehner T; Ebsen M; Kreuder J; Ruppert C; Guenther A; Reiss I
    BMC Pulm Med; 2008 Jul; 8():10. PubMed ID: 18625067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?
    Dushianthan A; Cusack R; Goss V; Postle AD; Grocott MP
    Crit Care; 2012 Nov; 16(6):238. PubMed ID: 23171712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome.
    Almlén A; Stichtenoth G; Linderholm B; Haegerstrand-Björkman M; Robertson B; Johansson J; Curstedt T
    J Appl Physiol (1985); 2008 Apr; 104(4):1101-8. PubMed ID: 18276900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous breathing or mechanical ventilation alters lung compliance and tissue association of exogenous surfactant in preterm newborn rabbits.
    Bohlin K; Bouhafs RK; Jarstrand C; Curstedt T; Blennow M; Robertson B
    Pediatr Res; 2005 May; 57(5 Pt 1):624-30. PubMed ID: 15718361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a peptide-containing synthetic lung surfactant on gas exchange and lung mechanics in a rabbit model of surfactant depletion.
    van Zyl JM; Smith J; Hawtrey A
    Drug Des Devel Ther; 2013; 7():139-48. PubMed ID: 23507973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-IL-8 antibody potentiates the effect of exogenous surfactant in respiratory failure caused by meconium aspiration.
    Mikolka P; Kopincova J; Kosutova P; Kolomaznik M; Calkovska A; Mokra D
    Exp Lung Res; 2018 Feb; 44(1):40-50. PubMed ID: 29324051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS.
    Wolfson MR; Wu J; Hubert TL; Gregory TJ; Mazela J; Shaffer TH
    Pediatr Res; 2012 Oct; 72(4):375-83. PubMed ID: 22821059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein- and lipid modification of natural bovine surfactant. Effects in experimental lung failure with special consideration of the response in neonates.
    Gortner L; Maroske W; Reiss I; Weller E
    Arzneimittelforschung; 2006; 56(1):25-32. PubMed ID: 16478002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study.
    Spengler D; Winoto-Morbach S; Kupsch S; Vock C; Blöchle K; Frank S; Rintz N; Diekötter M; Janga H; Weckmann M; Fuchs S; Schromm AB; Fehrenbach H; Schütze S; Krause MF
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L32-L53. PubMed ID: 28860142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early airway pressure release ventilation prevents ARDS-a novel preventive approach to lung injury.
    Roy S; Habashi N; Sadowitz B; Andrews P; Ge L; Wang G; Roy P; Ghosh A; Kuhn M; Satalin J; Gatto LA; Lin X; Dean DA; Vodovotz Y; Nieman G
    Shock; 2013 Jan; 39(1):28-38. PubMed ID: 23247119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the contribution of surfactant replacement therapy to the alveolar pool: An in vivo study based on
    Giambelluca S; Ricci F; Simonato M; Correani A; Casiraghi C; Storti M; Cogo P; Salomone F; Carnielli VP
    J Mass Spectrom; 2018 Jul; 53(7):560-564. PubMed ID: 29633450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.